339 related articles for article (PubMed ID: 34067647)
1. Milano-Torino Staging and Long-Term Survival in Chinese Patients with Amyotrophic Lateral Sclerosis.
He R; Zheng M; Lian L; Yao X
Cells; 2021 May; 10(5):. PubMed ID: 34067647
[TBL] [Abstract][Full Text] [Related]
2. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.
Tramacere I; Dalla Bella E; Chiò A; Mora G; Filippini G; Lauria G;
J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1180-5. PubMed ID: 25886781
[TBL] [Abstract][Full Text] [Related]
3. Neurophysiological indices in amyotrophic lateral sclerosis correlate with functional outcome measures, staging and disease progression.
Barp A; Lizio A; Gerardi F; Tarlarini C; Mauro L; Sansone VA; Lunetta C
Clin Neurophysiol; 2021 Jul; 132(7):1564-1571. PubMed ID: 34023632
[TBL] [Abstract][Full Text] [Related]
4. Deconstructing progression of amyotrophic lateral sclerosis in stages: a Markov modeling approach.
Thakore NJ; Lapin BR; Kinzy TG; Pioro EP
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):483-494. PubMed ID: 30001159
[TBL] [Abstract][Full Text] [Related]
5. MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial.
Gebrehiwet P; Meng L; Rudnicki SA; Sarocco P; Wei J; Wolff AA; Chiò A; Andrews JA; Genge A; Jackson CE; Lechtzin N; Miller TM; Shefner JM
Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):304-310. PubMed ID: 36503310
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the ability of the King's and MiToS staging systems to predict disease progression and survival in amyotrophic lateral sclerosis.
Luna J; Couratier P; Lahmadi S; Lautrette G; Fontana A; Tortelli R; Logroscino G; Preux PM; Copetti M; Benoit M
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):478-485. PubMed ID: 33829938
[No Abstract] [Full Text] [Related]
7. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis.
Chiò A; Hammond ER; Mora G; Bonito V; Filippini G
J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):38-44. PubMed ID: 24336810
[TBL] [Abstract][Full Text] [Related]
8. Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19.
Al-Chalabi A; Chiò A; Merrill C; Oster G; Bornheimer R; Agnese W; Apple S
J Neurol Neurosurg Psychiatry; 2021 Feb; 92(2):165-171. PubMed ID: 33109706
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the King's and MiToS staging systems for ALS.
Fang T; Al Khleifat A; Stahl DR; Lazo La Torre C; Murphy C; ; Young C; Shaw PJ; Leigh PN; Al-Chalabi A
Amyotroph Lateral Scler Frontotemporal Degener; 2017 May; 18(3-4):227-232. PubMed ID: 28054828
[TBL] [Abstract][Full Text] [Related]
10. Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study.
Ferraro D; Consonni D; Fini N; Fasano A; Del Giovane C; ; Mandrioli J
Eur J Neurol; 2016 Sep; 23(9):1426-32. PubMed ID: 27238551
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life across disease stages in patients with amyotrophic lateral sclerosis: results from a real-world survey.
Stenson K; Fecteau TE; O'Callaghan L; Bryden P; Mellor J; Wright J; Earl L; Thomas O; Iqbal H; Barlow S; Parvanta S
J Neurol; 2024 May; 271(5):2390-2404. PubMed ID: 38200398
[TBL] [Abstract][Full Text] [Related]
12. Health Utilities and Costs for Motor Neurone Disease.
Moore A; Young CA; Hughes DA
Value Health; 2019 Nov; 22(11):1257-1265. PubMed ID: 31708062
[TBL] [Abstract][Full Text] [Related]
13. Feasibility assessment of using the MiToS staging system for conducting economic evaluation in amyotrophic lateral sclerosis.
Gebrehiwet P; Aggarwal S; Topaloglu O; Chiò A
Expert Rev Pharmacoecon Outcomes Res; 2024 Mar; 24(3):447-458. PubMed ID: 38235589
[TBL] [Abstract][Full Text] [Related]
14. Association between depression and survival in Chinese amyotrophic lateral sclerosis patients.
Wei Q; Zheng Z; Guo X; Ou R; Chen X; Huang R; Yang J; Shang H
Neurol Sci; 2016 Apr; 37(4):557-63. PubMed ID: 26758858
[TBL] [Abstract][Full Text] [Related]
15. The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation.
Lo Coco D; Marchese S; La Bella V; Piccoli T; Lo Coco A
Chest; 2007 Jul; 132(1):64-9. PubMed ID: 17475635
[TBL] [Abstract][Full Text] [Related]
16. Could the motor unit number index be an early prognostic biomarker for amyotrophic lateral sclerosis?
Grapperon AM; Harlay V; Boucekine M; Devos D; Rolland AS; Desnuelle C; Delmont E; Verschueren A; Attarian S
Clin Neurophysiol; 2024 Jul; 163():47-55. PubMed ID: 38703699
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients.
Pirola A; De Mattia E; Lizio A; Sannicolò G; Carraro E; Rao F; Sansone V; Lunetta C
Clin Neurol Neurosurg; 2019 Sep; 184():105456. PubMed ID: 31382080
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.
Wei QQ; Hou Y; Chen Y; Ou R; Cao B; Zhang L; Yang T; Shang H
Health Qual Life Outcomes; 2021 Jul; 19(1):181. PubMed ID: 34284776
[TBL] [Abstract][Full Text] [Related]
19. Cognitive impairment across ALS clinical stages in a population-based cohort.
Chiò A; Moglia C; Canosa A; Manera U; Vasta R; Brunetti M; Barberis M; Corrado L; D'Alfonso S; Bersano E; Sarnelli MF; Solara V; Zucchetti JP; Peotta L; Iazzolino B; Mazzini L; Mora G; Calvo A
Neurology; 2019 Sep; 93(10):e984-e994. PubMed ID: 31409738
[TBL] [Abstract][Full Text] [Related]
20. What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis.
Rooney J; Burke T; Vajda A; Heverin M; Hardiman O
J Neurol Neurosurg Psychiatry; 2017 May; 88(5):381-385. PubMed ID: 27888187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
